General Information |
|
| NSE Symbol* | BETA |
| Name of the Company* | BETA DRUGS LIMITED |
| ISIN* | INE351Y01019 |
| Type of Meeting |
1) Board Meeting |
| Details of Committee Meeting or Other Type of Meeting | |
| Type of Intimation* | New |
| Reason for Re-schedule (postpone or prepone) / Cancellation | |
| Proposed Meeting Date | 2026-01-09 |
| Original Meeting Date | |
| Whether trading window is closed* | Yes |
| Trading Window Closure- Start date | 2026-01-01 |
| Details of Trading Window Closure End date | 2026-02-16 |
| Short Notice | |
| Date of Report* | 2026-01-06 |
Agenda Details |
|
| Agenda* |
1) ESOP 2) Other business |
| Whether results are audited or unaudited | |
| Nature of report standalone or consolidated | |
| Period end Type | |
| Period up to (Month) | |
| Period up to (Year) | |
| Mode of raising Funds | |
| Type of Dividend | |
| Remarks (website dissemination) | (a) acquisition of equity shares of a target company from certain shareholders of the target company; (b) issue certain equity shares to the shareholders of the target company on a preferential basis through the private placement route, as consideration other than cash in lieu of the acquired shares and (c) to consider and approve the Employee Stock Option Plan (ESOP). |